Human Upper Extremity Allotransplantation: F/U Protocol
| Status: | Recruiting |
|---|---|
| Conditions: | Hospital, Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry, Other |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 1/18/2019 |
| Start Date: | July 25, 2017 |
| End Date: | July 2026 |
| Contact: | Jane Littleton, C.R.N.P |
| Email: | jlittl38@jhmi.edu |
| Phone: | 410-955-6875 |
Human Upper Extremity Allotransplantation: Transplanted Patient Follow-Up Protocol
Upper extremity allotransplantation is a new procedure which is becoming more common in the
United States. Ongoing data collection for research purposes is vital to the long-term
assessment as to the safety of the procedure and accompanying immunosuppression protocol, as
well as quantifying patient outcomes and changes in quality of life. For these reasons, The
Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients
in a follow-up protocol to continue collecting informative data to further the field of
vascularized composite allotransplantation.
United States. Ongoing data collection for research purposes is vital to the long-term
assessment as to the safety of the procedure and accompanying immunosuppression protocol, as
well as quantifying patient outcomes and changes in quality of life. For these reasons, The
Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients
in a follow-up protocol to continue collecting informative data to further the field of
vascularized composite allotransplantation.
Inclusion Criteria:
- Males and females 5 or more years post-unilateral or bilateral upper limb
transplantation.
- Completes the protocol informed consent form.
- Consents to sample collection and storage (biopsies).
- USA citizen or equivalent.
- Patient agrees to comply with the protocol and states a dedication to the
immunomodulatory treatment regime.
Exclusion Criteria:
- Candidate has not received an upper extremity allotransplant.
- Any reason the study team thinks would cause the participant to be noncompliant or
would put the patient at unacceptable risk if enrolled.
We found this trial at
1
site
733 North Broadway
Baltimore, Maryland 21205
Baltimore, Maryland 21205
(410) 955-3182
Principal Investigator: W. P. Andrew Lee, MD
Phone: 443-287-4629
Johns Hopkins University School of Medicine Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is...
Click here to add this to my saved trials
